Aspirin and steroids: New mechanistic findings and avenues for drug discovery

Current Opinion in Pharmacology

Volumn 5, Issue 4 SPEC. ISS., 2005, Pages 405-411

  Gilroy, Derek W ^a   Perretti, Mauro ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; INDOMETACIN; LIPOCORTIN 1; LIPOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISOLONE; SALICYLIC ACID; STEROID;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; DRUG DESIGN; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; DRUG SYNTHESIS; HUMAN; INFECTION; INFLAMMATION; INJURY; NONHUMAN; ORGANIC CHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 21644455591     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.02.006     Document Type: Review

References (39)

1. J. Vane R. Botting In Aspirin and other salicylates Edited by J. Vane R. Botting 1992 Chapman & Hall London
2. M.W. Whitehouse J.M. Haslam Ability of some antirheumatic drugs to uncouple oxidative phosphorylation Nature 196 1962 1323-1324
3. W.J. Hines M.J. Smith Inhibition of dehydrogenases by salicylate Nature 201 1964 192
4. B.J. Gould M.J. Smith Salicylate and aminotransferases J Pharm Pharmacol 17 1965 83-88
5. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232-235
6. K.I. Williams G.A. Higgs Eicosanoids and inflammation J Pathol 156 1988 101-110
7. P.S. Hench E.C. Kendall C.H. Slocumb H.E. Polley The effect of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report Proc Staff Meet Mayo Clin 24 1949 181-187
8. A. Munck P.M. Guyre Glucocorticoid physiology, pharmacology and stress Adv Exp Med Biol 196 1986 81-96
9. R.J. Flower L. Parente P. Persico J.A. Salmon A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats Br J Pharmacol 87 1986 57-62
10. M. Perretti C. Becherucci G. Scapigliati L. Parente The effect of adrenalectomy on interleukin-1 release in vitro and in vivo Br J Pharmacol 98 1989 1137-1142
11. I.M. Adcock Molecular mechanisms of glucocorticosteroid actions Pulm Pharmacol Ther 13 2000 115-126
12. N. Auphan J.A. DiDonato C. Rosette A. Helmberg M. Karin Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 1995 286-290
13. M. Karin New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable? Cell 93 1998 487-490
14. F. Buttgereit G.R. Burmester M.D. Brand Bioenergetics of immune functions: Fundamental and therapeutic aspects Immunol Today 21 2000 192-199
15. J. Claria C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc Natl Acad Sci USA 92 1995 9475-9479
16. C.N. Serhan T. Takano C.B. Clish K. Gronert N. Petasis Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability Adv Exp Med Biol 469 1999 287-293
17. M. Perretti N. Chiang M. La I.M. Fierro S. Marullo S.J. Getting E. Solito C.N. Serhan Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor Nat Med 8 2002 1296-1302
18. J.F. Maddox M. Hachicha T. Takano N.A. Petasis V.V. Fokin C.N. Serhan Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor J Biol Chem 272 1997 6972-6978
19. J.F. Maddox C.N. Serhan Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction J Exp Med 183 1996 137-146
20. L. Jozsef C. Zouki N.A. Petasis C.N. Serhan J.G. Filep Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes Proc Natl Acad Sci USA 99 2002 13266-13271
21. C. Godson S. Mitchell K. Harvey N.A. Petasis N. Hogg H.R. Brady Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages J Immunol 164 2000 1663-1667
22. S. Mitchell G. Thomas K. Harvey D. Cottell K. Reville G. Berlasconi N.A. Petasis L. Erwig A.J. Rees J. Savill et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: Stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J Am Soc Nephrol 13 2002 2497-2507
23. M.J. Paul-Clark T. Van Cao N. Moradi-Bidhendi D. Cooper D.W. Gilroy 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation J Exp Med 200 2004 69-78
24. S. Fiorucci E. Distrutti O.M. de Lima M. Romano A. Mencarelli M. Barbanti E. Palazzini A. Morelli J.L. Wallace Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin FASEB J 17 2003 1171-1173
25. S. Fiorucci L. Santucci J.L. Wallace M. Sardina M. Romano P. del Soldato A. Morelli Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Proc Natl Acad Sci USA 100 2003 10937-10941
26. N. Chiang E.A. Bermudez P.M. Ridker S. Hurwitz C.N. Serhan Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial Proc Natl Acad Sci USA 101 2004 15178-15183
27. D.N. Granger P. Kubes The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion J Leukoc Biol 55 1994 662-675
28. B.P. Wallner R.J. Mattaliano C. Hession R.L. Cate R. Tizard L.K. Sinclair C. Foeller E.P. Chow J.L. Browing K.L. Ramachandran et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity Nature 320 1986 77-81
29. M. Perretti Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation Gen Pharmacol 31 1998 545-552
30. Y.H. Yang E.F. Morand S.J. Getting M. Paul-Clark D.L. Liu S. Yona R. Hannon J.C. Buckingham M. Perretti R.J. Flower Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis Arthritis Rheum 50 2004 976-984
31. R. Hannon J.D. Croxtall S.J. Getting F. Roviezzo S. Yona M.J. Paul-Clark F.N. Gavins M. Perretti J.F. Morris J.C. Buckingham et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse FASEB J 17 2003 253-255
32. L. Minghetti A. Nicolini E. Polazzi A. Greco M. Perretti L. Parente G. Levi Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1 Br J Pharmacol 126 1999 1307-1314
33. J.D. Croxtall R.J. Flower Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line Proc Natl Acad Sci USA 89 1992 3571-3575
34. R. De Caterina R. Sicari D. Giannessi P.L. Paggiaro P. Paoletti G. Lazzerini W. Bernini E. Solito L. Parente Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids J Appl Physiol 75 1993 2368-2375
35. M. Perretti F.N. Gavins Annexin 1: An endogenous anti-inflammatory protein News Physiol Sci 18 2003 60-64
36. V. Gerke S.E. Moss Annexins: From structure to function Physiol Rev 82 2002 331-371
37. M. Perretti The annexin 1 receptor(s): Is the plot unravelling? Trends Pharmacol Sci 24 2003 574-579
38. B. McMahon S. Mitchell H.R. Brady C. Godson Lipoxins: Revelations on resolution Trends Pharmacol Sci 22 2001 391-395
39. Y. Le P.M. Murphy J.M. Wang Formyl-peptide receptors revisited Trends Immunol 23 2002 541-548